Working towards harmonization of clinical trial reporting in Hodgkin lymphoma
The workshop resulted in practical recommendations to improve consistency and efficiency in HL clinical trials.
The recommendations aim to enhance the quality, comparability, and efficiency of future trials while reducing the unnecessary burden of data collection and radiation exposure for patients.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.
- Overcoming PD‑1 Resistance in Relapsed/Refractory Hodgkin Lymphoma
- Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era
- Combination of Acimtamig and AlloNK Effective in R/R Classical Hodgkin Lymphoma
- Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies